Amifostine (WR-2721) Protects Normal Haematopoietic Stem Cells Against Cyclophosphamide Derivatives' Toxicity Without Compromising Their Antileukaemic Effects
- 31 December 1995
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31, S14-S16
- https://doi.org/10.1016/0959-8049(95)00146-a
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- New Protective Agents for Bone Marrow in Cancer TherapyCancer Investigation, 1991
- CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4- hydroperoxycyclophosphamide-purged bone marrowBlood, 1987
- Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamideBlood, 1980